aTyr Pharma to Present at November Investor Conferences
November 01 2023 - 8:00AM
aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology
company engaged in the discovery and development of first-in-class
medicines from its proprietary tRNA synthetase platform, today
announced that Sanjay S. Shukla, M.D., M.S., President and Chief
Executive Officer, will present at two upcoming investor
conferences scheduled to take place in November 2023.
Details of the presentations appear below:
Conference: Jefferies London Healthcare ConferenceDate:
Wednesday, November 15, 2023 Time: 3:30pm GMTLocation: London,
UKFormat: Corporate Presentation
Conference: Piper Sandler 35th Annual Healthcare ConferenceDate:
Thursday, November 30, 2023Time: 12:00pm ESTLocation: New York,
NYFormat: Fireside Chat
In addition to the presentations, company
management will be available to participate in one-on-one meetings
with investors who are registered attendees of the conferences. A
webcast of each event will be available on the Investor’s section
of the company’s website at www.atyrpharma.com. Following the
events, a replay of the presentations will be available on the aTyr
website for at least 90 days.
About aTyr
aTyr is a clinical stage biotechnology company
leveraging evolutionary intelligence to translate tRNA synthetase
biology into new therapies for fibrosis and inflammation. tRNA
synthetases are ancient, essential proteins that have evolved novel
domains that regulate diverse pathways extracellularly in humans.
aTyr’s discovery platform is focused on unlocking hidden
therapeutic intervention points by uncovering signaling pathways
driven by its proprietary library of domains derived from all 20
tRNA synthetases. aTyr’s lead therapeutic candidate is efzofitimod,
a first-in-class biologic immunomodulator in clinical development
for the treatment of interstitial lung disease, a group of
immune-mediated disorders that can cause inflammation and
progressive fibrosis, or scarring, of the lungs. For more
information, please visit www.atyrpharma.com.
Contact:Ashlee DunstonDirector, Investor
Relations and Public Affairsadunston@atyrpharma.com
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2023 to Apr 2024